East Hampton, CT, United States of America

Bradley C Pearce

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 141(Granted Patents)


Company Filing History:


Years Active: 1993-2021

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Bradley C. Pearce**

Introduction

Bradley C. Pearce, based in East Hampton, Connecticut, is a prolific inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 18 patents, he has developed groundbreaking compounds aimed at treating serious health conditions, including viral infections and cancer.

Latest Patents

Two of Bradley's latest patents showcase his innovative approach to drug development. The first patent, titled "Isofuranone Compounds Useful as HPK1 Inhibitors," discloses compounds designed to modulate or inhibit the enzymatic activity of hematopoietic progenitor kinase 1 (HPK1). These compounds are promising candidates for the treatment of viral infections and proliferative disorders, such as cancer.

The second patent involves "Substituted 4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine Derivatives as Casein Kinase 1 D/E Inhibitors." This invention presents compounds that inhibit protein kinase activity, positioning them as potential anticancer agents. Both patents reflect Pearce's commitment to addressing critical medical challenges through innovative solutions.

Career Highlights

Bradley C. Pearce is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm known for its cutting-edge research and development initiatives. His work at this esteemed company has allowed him to collaborate with some of the brightest minds in the industry while making impactful advancements in therapeutic technologies.

Collaborations

Throughout his career, Bradley has had the opportunity to work alongside talented colleagues such as John J. Wright and Nicholas A. Meanwell. These collaborations have fostered an environment of innovation, enabling them to push the boundaries of what is possible in the pharmaceutical realm.

Conclusion

Bradley C. Pearce exemplifies the spirit of innovation, consistently contributing to the landscape of medicinal chemistry with his patents and research. His ongoing efforts at Bristol-Myers Squibb Company highlight a dedication to improving healthcare outcomes, demonstrating that innovative minds can indeed change the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…